» Articles » PMID: 29340865

Design of a Tripartite Network for the Prediction of Drug Targets

Overview
Publisher Springer
Date 2018 Jan 18
PMID 29340865
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Drug-target networks have aided in many target prediction studies aiming at drug repurposing or the analysis of side effects. Conventional drug-target networks are bipartite. They contain two different types of nodes representing drugs and targets, respectively, and edges indicating pairwise drug-target interactions. In this work, we introduce a tripartite network consisting of drugs, other bioactive compounds, and targets from different sources. On the basis of analog relationships captured in the network and so-called neighbor targets of drugs, new drug targets can be inferred. The tripartite network was found to have a stable structure and simulated network growth was accompanied by a steady increase in assortativity, reflecting increasing correlation between degrees of connected nodes leading to even network connectivity. Local drug environments in the tripartite network typically contained neighbor targets and revealed interesting drug-compound-target relationships for further analysis. Candidate targets were prioritized. The tripartite network design extends standard drug-target networks and provides additional opportunities for drug target prediction.

Citing Articles

Novel bacterial taxa in a minimal lignocellulolytic consortium and their potential for lignin and plastics transformation.

Diaz Rodriguez C, Diaz-Garcia L, Bunk B, Sproer C, Herrera K, Tarazona N ISME Commun. 2023; 2(1):89.

PMID: 37938754 PMC: 9723784. DOI: 10.1038/s43705-022-00176-7.


Machine Learning Toxicity Prediction: Latest Advances by Toxicity End Point.

Cavasotto C, Scardino V ACS Omega. 2023; 7(51):47536-47546.

PMID: 36591139 PMC: 9798519. DOI: 10.1021/acsomega.2c05693.


A Machine Learning-Based Biological Drug-Target Interaction Prediction Method for a Tripartite Heterogeneous Network.

Zheng Y, Wu Z ACS Omega. 2021; 6(4):3037-3045.

PMID: 33553921 PMC: 7860102. DOI: 10.1021/acsomega.0c05377.


Uncovering New Drug Properties in Target-Based Drug-Drug Similarity Networks.

Udrescu L, Bogdan P, Chis A, Sirbu I, Topirceanu A, Varut R Pharmaceutics. 2020; 12(9).

PMID: 32947845 PMC: 7557376. DOI: 10.3390/pharmaceutics12090879.


Data-Driven Exploration of Selectivity and Off-Target Activities of Designated Chemical Probes.

Miljkovic F, Bajorath J Molecules. 2018; 23(10).

PMID: 30249057 PMC: 6222907. DOI: 10.3390/molecules23102434.

References
1.
Paolini G, Shapland R, van Hoorn W, Mason J, Hopkins A . Global mapping of pharmacological space. Nat Biotechnol. 2006; 24(7):805-15. DOI: 10.1038/nbt1228. View

2.
Yildirim M, Goh K, Cusick M, Barabasi A, Vidal M . Drug-target network. Nat Biotechnol. 2007; 25(10):1119-26. DOI: 10.1038/nbt1338. View

3.
Wang L, Bao S, Pan P, Xia M, Chen M, Liang B . Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro. Drug Dev Ind Pharm. 2014; 41(8):1363-7. DOI: 10.3109/03639045.2014.950274. View

4.
Smoot M, Ono K, Ruscheinski J, Wang P, Ideker T . Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2010; 27(3):431-2. PMC: 3031041. DOI: 10.1093/bioinformatics/btq675. View

5.
Boran A, Iyengar R . Systems approaches to polypharmacology and drug discovery. Curr Opin Drug Discov Devel. 2010; 13(3):297-309. PMC: 3068535. View